Updates
-
-
Independent Mouse Study Reinforces Remyelinating Potential of ISP Therapy
A new study demonstrates that intracellular sigma peptide (ISP) can promote remyelination in a mouse model of multiple sclerosis (MS). Importantly, this study was ... Read more -
3-D Brain Models of PPMS and Parkinson’s Off to Space Station for Research in Microgravity
The National Stem Cell Foundation announced the start of a pioneering project to investigate the impact of microgravity on the neurodegeneration associated with primary progressive ... Read more -
MS News that Caught My Eye Last Week: Gadolinium Study, Breath Test for MS Diagnosis, CBD Treatment Trial, Potential Remyelination Therapy
Study Examines Gadolinium Deposits in MS Patients’ Brains, But Still Can’t Determine Relationship with Disease Severity Here’s some new information about gadodiamide, a contrast ... Read more -
MS Possibly Linked to Greater Cancer Risk in Large, But Preliminary Norwegian Study
People with multiple sclerosis (MS) may have a greater overall risk of developing cancer than the general population, according to the results of a ... Read more
-
What can changes in grey matter mean for MS? (Sponsored Post)
The brain is made up of two types of tissue: grey matter and white ... -
CMSC Opens Weeklong Mental Health Program to Help Mentor and Train MS Specialists
The Consortium of Multiple Sclerosis Centers (CMSC), working with the Foundation of the CMSC ... -
Tools May Endure, but They Need Human Hands to Realize Their Potential
For the last two weeks or so, I’ve begun my mornings by slapping on ... -
Eight Days a Week
It was such a jam-packed week that the flavor was definitely multi-fruit! It included ... -
Study Examines Gadolinium Deposits in MS Patients’ Brains, But Still Can’t Determine Relationship with Disease Severity
The use of gadodiamide, a gadolinium-based contrast agent (GBCA) often used to help clinicians ... -
Phase 2 Trial Testing NurOwn Therapy for Progressive MS Adds Third Clinical Site
The Phase 2 clinical trial testing BrainStorm Cell Therapeutic’s investigational NurOwn therapy for progressive multiple sclerosis ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more